Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma

BACKGROUND: The present study aimed to assess the efficacy and safety of lenvatinib and verify the possibility of lenvatinib for the expanded indication from the REFLECT trial in patients with advanced hepatocellular carcinoma (HCC) in real-world practice, primarily focusing on the population that w...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Liver Cancer
Egile Nagusiak: Maruta, Susumu, Ogasawara, Sadahisa, Ooka, Yoshihiko, Obu, Masamichi, Inoue, Masanori, Itokawa, Norio, Haga, Yuki, Seki, Atsuyoshi, Okabe, Shinichiro, Azemoto, Ryosaku, Itobayashi, Ei, Atsukawa, Masanori, Sugiura, Nobuyuki, Mizumoto, Hideaki, Koroki, Keisuke, Kanayama, Kengo, Kanzaki, Hiroaki, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Saito, Tomoko, Kondo, Takayuki, Suzuki, Eiichiro, Nakamoto, Shingo, Tawada, Akinobu, Chiba, Tetsuhiro, Arai, Makoto, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Naoya
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: S. Karger AG 2020
Gaiak:
Original Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7506220/
https://ncbi.nlm.nih.gov/pubmed/32999866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000507022
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak